News About: Pharm. Industry
Sales of multilevel marketers plunge last year
Sales at multilevel marketing companies in 2006 decreased sharply from a year ago, weighed down by the corruption scandal of JU Group, the country's largest network marketing company, with a market share of more than ...
Plavix ranking the top of the top 100 drugs in Korea.
Plavix, produced and distributed by Sanofi-Aventis Korea took the top position among the top 100 drugs in 2006 according to the KPMA report titled "Top 100 drugs produced in 2006" released on June 28.
Abilify, an a...
Competition will heat up in anti-obesity medicine market
Competition is about to heat up in the domestic anti-obesity medicines market, as the US-based Abbott Reductil's patent is scheduled for expiration on this July 1 and a number of its generics are lining up side by sid...
Prices of major OTC drugs raised 10% in July.
Taking effect from July the prices of major non-prescription drugs including Dongwha's Fucidin will be 10% up on average.
Madecasol (Dongkuk), an ointment for burn wound treatment, raised its price by 10% effectiv...
Lilly, market launching of Strattera for ADHD treatment.
Lilly Korea announced market launching of Strattera (atomoxetine), an ADHD therapeutic drug, having 24 hour sustained activity by once a day administration.
Strattera (atomoxetine), a new non-stimulant drug to tre...
Top 100 companies made 87% of total pharmaceutical production.
The total pharmaceutical production in 2006 reported 12,362,031,380 thousand, of which the top 100 companies produced 87.35% at 10,798,121,600 thousand, the top 20 companies 44.09% at 5,450,079,400 thousand and the t...
Chong Kun Dang, Hanall to benefit from U.S. court ruling over Plavix
Some domestic drug manufacturers, such as Chong Kun Dang Pharmaceutical and Hanall Pharm, who are using a different salt from Sanifi-Aventis's Plavix (clopidogrel bisulfate) will strengthen their presence in local ant...
Daewoong to launch anti-obesity agent 'NBU'
Daewoong Pharm will begin its anti-obesity agent that is called NBU (sibutramine), a prosumer based trade name, from next month.
Prosumer is a portmanteau formed by contracting either the word professional with the...
Ethical sales grow 12% in May
The domestic ethical market for outpatients in May grew 12.3 percent to 593.3 billion won, compared to the same period last year, according to pharmaceutical business sources.
Korea major ten drug makers recorded 2...
MSD rotavirus vaccine approved to launch market
The KFDA approved Rotateq for the prevention of infant's viral infections in the gastrointestinal tracts by G1, G2, G3, G4, G9PIA (8) types of rotavirus.
The market distribution of Rotateq and customers servic...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
March
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
23 | 24 | 25 | 26 | 27 | 28 | 1 |
2 | 3 | 4 | 5 | 6 | 7 | 8 |
9 | 10 | 11 | 12 | 13 | 14 | 15 |
16 | 17 | 18 | 19 | 20 | 21 | 22 |
23 | 24 | 25 | 26 | 27 | 28 | 29 |
30 | 31 | 1 | 2 | 3 | 4 | 5 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
